Search - tctmd.com

Displaying 21 - 40 of 270

Sort: Relevancy | Date

News Daily News

People With Tricuspid Valve Disease Want More Information, Sooner

Yael L. Maxwell

July 17, 2025

News Conference News NY Valves 2025

Promising Early Data With Navitor TAVI Valves

Yael L. Maxwell

July 02, 2025

News Conference News NY Valves 2025

Changes in Quality of Life Mirror TR Reductions After Tricuspid Procedures: Tri-QOL

Yael L. Maxwell

July 01, 2025

News Conference News NY Valves 2025

Failure of ‘Jailed’ CIED Leads Not Uncommon After TTVR: TRIPLACE

Todd Neale

June 27, 2025

News Opinion CV Team Dispatch

June 2025 Dispatch for the CV Team

L.A. McKeown

June 26, 2025

Presentation NY Valves 2025

Is There a Rebound Favoring Surgery for Severe TR… Or Is RHF Still an Exclusion

Presenter: Robert L. Smith

June 26, 2025

Presentation NY Valves 2025

Redo Transcatheter Interventions: Recurrent Severe Tricuspid Regurgitation in a Patient With Prior ViV TTVR

Presenter: Amr Mohsen

June 26, 2025

Presentation NY Valves 2025

Transcatheter Tricuspid Valve Replacement Beyond Age 75: 30-Day Outcomes in Severe Tricuspid Regurgitation

Presenter: Priscilla Wessly

June 26, 2025

Presentation NY Valves 2025

Case #1: A Patient With Symptomatic Severe TR: Repair or Replace?

Presenter: Jennifer von Stein

June 25, 2025

Presentation NY Valves 2025

Efficacy and Safety of Transcatheter Therapy for Patients With Severe Tricuspid Regurgitation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Presenter: John Cedric Mojica

June 25, 2025

News Daily News

‘Sobering’ Adverse Event Rate With Evoque Seen in Real-world Use

Yael L. Maxwell

June 18, 2025

News Daily News

LuX-Valve TTVR Device Provides Favorable 1-Year Results

Yael L. Maxwell

April 24, 2025

News Daily News

CMS Releases Proposed Decision Memo for Tricuspid TEER

L.A. McKeown

April 04, 2025

News Conference News ACC 2025

By 2 Years, Tricuspid TEER Reduces Hospitalizations for HF: TRILUMINATE

Michael O'Riordan

March 31, 2025

News Opinion Editor's Corner ACC 2025

What’s Going to Be Hot at ACC 2025?

Michael O'Riordan

March 26, 2025

News Daily News

CMS Agrees to Reimburse Transcatheter Tricuspid Valve Replacement

Todd Neale

March 20, 2025

News Conference News THT 2025

Questioning the KCCQ: Experts Debate Its Validity as QoL Metric

Todd Neale

February 19, 2025

Presentation THT Abstracts 2025

TRISCEND II Trial: Right Heart Failure Outcomes in Patients With Severe Tricuspid Regurgitation at One Year

Presenter: Aasim Afzal

February 11, 2025

Presentation THT 2025

TRISCEND II Trial: Right Heart Failure Outcomes in Patients With Severe Tricuspid Regurgitation at One Year

Presenter: Aasim Afzal

February 11, 2025

News Conference News STS 2025

Surgeons: Be Active in Tricuspid Procedures or Be ‘Left Behind’

Yael L. Maxwell

February 05, 2025

Advertisement

People With Tricuspid Valve Disease Want More Information, Sooner

Promising Early Data With Navitor TAVI Valves

Changes in Quality of Life Mirror TR Reductions After Tricuspid Procedures: Tri-QOL

Failure of ‘Jailed’ CIED Leads Not Uncommon After TTVR: TRIPLACE

June 2025 Dispatch for the CV Team

Is There a Rebound Favoring Surgery for Severe TR… Or Is RHF Still an Exclusion

Redo Transcatheter Interventions: Recurrent Severe Tricuspid Regurgitation in a Patient With Prior ViV TTVR

Transcatheter Tricuspid Valve Replacement Beyond Age 75: 30-Day Outcomes in Severe Tricuspid Regurgitation

Case #1: A Patient With Symptomatic Severe TR: Repair or Replace?

Efficacy and Safety of Transcatheter Therapy for Patients With Severe Tricuspid Regurgitation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

‘Sobering’ Adverse Event Rate With Evoque Seen in Real-world Use

LuX-Valve TTVR Device Provides Favorable 1-Year Results

CMS Releases Proposed Decision Memo for Tricuspid TEER

By 2 Years, Tricuspid TEER Reduces Hospitalizations for HF: TRILUMINATE

What’s Going to Be Hot at ACC 2025?

CMS Agrees to Reimburse Transcatheter Tricuspid Valve Replacement

Questioning the KCCQ: Experts Debate Its Validity as QoL Metric

TRISCEND II Trial: Right Heart Failure Outcomes in Patients With Severe Tricuspid Regurgitation at One Year

TRISCEND II Trial: Right Heart Failure Outcomes in Patients With Severe Tricuspid Regurgitation at One Year

Surgeons: Be Active in Tricuspid Procedures or Be ‘Left Behind’

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content